# US 2024/0189145 A1 · Tunable device for treating eye disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189145 A1
- Document ID: US20240189145A1
- Status: Published application
- Kind: A1
- Application number: 18/553,085
- Filed: 2022-04-01
- Published: 2024-06-13
- Earliest claimed: 2021-04-01
- Assignees: Avisi Technologies, Inc.
- Applicants: Avisi Technologies, Inc.
- Inventors: Rui Jing Jiang; Brandon Kao; Georgia Griggs; Jeffrey Lorne Emery
- Web page: https://patentgrep.com/patent/US20240189145A1

## CPC

- A61F 9/00781: {Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002)}
- A61F 2230/0017: Angular shapes
- A61F 2240/001: Designing or manufacturing processes
- A61F 2240/002: Designing or making customized prostheses
- A61F 2250/0097: Visible markings, e.g. indicia
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Described herein are tunable treatment devices used to treat various diseases such as high intraocular pressure and glaucoma. A treatment device (1) includes a plate structure (200) that is modified based on a treatment application. The mechanical properties of the treatment device (1) may be tuned to achieve a desired bending stiffness, flow rate, and/or tensile elasticity. The mechanical properties may be tuned by changing an overall device shape, device thickness, core materials, and/or channel dimensions. For example, the treatment device (1) can be tuned to have a greater flow rate to treat patients that have higher intraocular pressures. In another example, a core thickness of the treatment device (1) may be increased, thereby increasing bending stiffness to improve surgical handling and reduce a likelihood of folding after implantation. Further, a tensile elasticity of the treatment device may be changed to reduce mechanical strain on surrounding tissue.

## Claims

### Claim at position 1

1: A device for lowering intraocular pressure, the device comprising:
a plate comprising a first surface opposite a second surface, wherein the first surface includes interconnected fluid channels;
a first coating on the first surface; and
a second coating on the second surface,
wherein at least one of the first surface or the second surface includes a marking that is visible under at least one of visible, ultraviolent, or infrared light for intraoperative or post-operative monitoring.

### Claim at position 2 (depends on 1)

2: The device according to claim 1, wherein the fluid channels form a hexagonal pattern with each channel having a height and first width to produce a desired fluid flow rate.

### Claim at position 3 (depends on 1)

3: The device according to claim 1, wherein a first portion of the plate has a first thickness and a second portion of the plate has a second thickness.

### Claim at position 4 (depends on 3)

4: The device according to claim 3, wherein the first thickness is greater than the second thickness.

### Claim at position 5 (depends on 3)

5: The device according to claim 3, wherein the first portion includes an extension portion and the second portion includes a main body portion.

### Claim at position 6 (depends on 1)

6: The device according to claim 1, wherein the interconnected fluid channels have dimensions between 10×14 and 12×18 micrometers (“μm”) and the plate includes a neck width between 2 and 5 millimeters (“mm”).

### Claim at position 7 (depends on 1)

7: The device according to claim 1, wherein the plate is formed from a ceramic material selected from the group consisting of alumina, silicon nitride, silica, hafnium oxide, titanium nitride, and titanium carbide.

### Claim at position 8 (depends on 1)

8: The device according to claim 1, wherein the first coating has a thickness of about 0.1 μm to about 10 μm.

### Claim at position 9 (depends on 1)

9: The device according to claim 1, wherein the first coating is a parylene polymer including at least one of parylene C, parylene D, parylene N, a derivative thereof, or a combination thereof.

### Claim at position 10 (depends on 1)

10: The device according to claim 1, wherein the second coating is aluminum oxide or a parylene polymer.

### Claim at position 11 (depends on 1)

11: The device according to claim 1, wherein at least one of the first coating or the second coating includes at least one of a biocompatible film, a porous coating, or a lubricious coating.

### Claim at position 12 (depends on 11)

12: The device according to claim 11, wherein the biocompatible film includes polytetrafluoroethylene (PTFE) or enhanced PTFE.

### Claim at position 13 (depends on 1)

13: The device of claim 1, wherein the series of fluid channels includes a plurality of open-ended channels that are interconnected to form an intersecting grid pattern of fluid pathways.

### Claim at position 14 (depends on 1)

14: The device of claim 1, wherein the plate has a core thickness between 300 and 800 nanometers.

### Claim at position 15 (depends on 1)

15: The device of claim 1, wherein the plate structure includes at least one notch along a perimeter, the notch being indicative as to whether the first surface or the second surface is visible to a surgeon.

### Claim at position 16 (depends on 1)

16: The device of claim 1, wherein the plate structure includes at least one geometric feature for attachment to patient tissue.

### Claim at position 17

17: A method of fabricating a device for a treatment application for lowering tissue or organ fluid pressure, the method comprising:
receiving at least one of an input of mechanical properties or a treatment application for the device;
determining dimensions of the device based on the input;
preparing a mold, substrate, or wafer using photolithography and reactive ion etching to achieve the determined dimensions including a hexagonal pattern of fluid microchannels;
depositing a layer of aluminum oxide to form the device;
removing the mold, substrate, or wafer;
coating the device with a parylene polymer; and
cutting the device based on the determined dimensions.

### Claim at position 18 (depends on 17)

18: The method according to claim 17, wherein the treatment application includes at least one of: lowering intraocular pressure, glaucoma, hydrocephalus, plastic surgery drainage of hematoma, seroma, or serous fluids, cell growth, a delivery of cells, a delivery of nucleic acids, a delivery of nanoparticles, or a conduit for a delivery of drugs.

### Claim at position 19 (depends on 17)

19: The method of claim 17, wherein the dimensions of the device include at least one of a thickness of the device, dimensions of the device, a thickness of the coating, dimensions of fluid microchannels channels, or dimensions of open cells.

### Claim at position 20 (depends on 17)

20: The method of claim 17, wherein the mechanical properties include at least one of a desired bending stiffness, a tensile elasticity, or a fluid flow rate.

### Claim at position 21 (depends on 17)

21: The method of claim 17, wherein a first portion of the device is formed to have a first thickness and a second portion of the device is formed to have a second thickness.

### Claim at position 22 (depends on 21)

22: The method according to claim 21, wherein the first thickness is greater than the second thickness.

### Claim at position 23 (depends on 17)

23: The method of claim 17, wherein the dimensions are additionally determined based on patient placement information.

### Claim at position 24 (depends on 17)

24: The method of claim 17, wherein the layer of aluminum oxide is deposited at a specified thickness based on the determined dimensions.
